Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
09/1991
09/25/1991EP0448213A2 The use of retinoids to minimize skin damage
09/25/1991EP0378671A4 Insulinomimetic and insulin receptor binding site peptides
09/25/1991CN1054766A Urea derivatives and salts thereof, pharmaceutical compositions containing same, and methods for producing same
09/24/1991US5051534 Novel cyclopropyl squalene derivatives and their use as inhibitors of cholesterol synthesis
09/24/1991US5051412 Compounds which may be used as psychotherapeutics for treatment of depression, obesity and aggression
09/24/1991CA1289569C Diphosphonic acid derivatives, processes for the preparation thereofand pharmaceutical compositions containing them
09/23/1991WO1991014447A1 MOLECULAR CLONING OF THE GENES RESPONSIBLE FOR COLLAGENASE PRODUCTION FROM $i(CLOSTRIDIUM HISTOLYTICUM)
09/23/1991CA2078783A1 Molecular cloning of the genes responsible for collagenase production from clostridium histolyticum
09/22/1991CA2038517A1 Squalene synthetase inhibitors
09/22/1991CA2038450A1 Squalene synthetase inhibitors
09/20/1991WO1991014683A1 Topically active ocular gem-diacylthiadiazole sulfonamide carbonic anhydrase inhibitors
09/20/1991WO1991014682A1 Topically active ocular benzothiazole sulfonamide carbonic anhydrase inhibitors
09/20/1991WO1991014430A1 Topically active ocular thiadiazole sulfonamide carbonic anhydrase inhibitors
09/20/1991CA2095050A1 Topically active ocular benzothiazole sulfonamide carbonic anhydrase inhibitors
09/20/1991CA2078669A1 Topically active ocular thiadiazole sulfonamide carbonic anhydrase
09/20/1991CA2077995A1 Topically active ocular gem-diacylthiadiazole sulfonamide carbonic anhydrase inhibitors
09/20/1991CA2038527A1 Therapeutic agent for ischemic diseases
09/19/1991WO1991013615A1 New use of bambuterol
09/18/1991EP0447325A1 Novel ascorbic acid derivatives
09/18/1991EP0447292A1 4-Aminomethyl-piperidine derivatives, their preparation and therapeutic application
09/18/1991EP0447116A1 Urea derivatives, their production, and pharmaceutical compositions containing them
09/18/1991EP0446751A1 Glycolic acid derivatives
09/18/1991EP0446699A1 Inhibitors of nitric oxide biosynthesis
09/18/1991EP0446539A1 Novel ascorbic acid derivatives
09/18/1991CN1054589A Crystalline salt of 4-(di-n-propyl) amino-6-aminocarbonyl-1,3,4,5-tetrahydrohbenz(cd) indole
09/17/1991WO1991013876A1 Imidazoles
09/17/1991WO1991013619A1 Nitroxides as protectors against oxidative stress
09/17/1991US5049695 Allosteric hemoglobin modifiers
09/17/1991US5049637 5-hydroxytryptamine antagonist
09/17/1991US5049556 Certain N-azabicyclo-2,3-dihydro-indole-1-carboxamides having anti-emetic properties, further found useful in treating headaches, neuralgia and anxiety
09/17/1991US5049545 Insulin derivatives, a process for their preparation, and their use
09/17/1991CA2078208A1 Imidazoles
09/17/1991CA2038282A1 Glycolic acid derivatives
09/17/1991CA1289139C Quinazoline derivatives and a process for their production
09/17/1991CA1289079C Method of treating diabetes with 5-[1-hydroxy-2- (isopropylamino)-ethyl]anthranilonitrile
09/17/1991CA1289000C Animal feed block compositions
09/16/1991CA2038259A1 Processes and intermediates for the preparation of 5-oxygenated hmg-c0a reductase inhibitors
09/13/1991CA2037669A1 Urea derivatives and salts thereof, pharmaceutical compositions containing the same, and methods for producing the same
09/11/1991EP0446140A1 Pyrrolo(1,2-a)thieno(3,2-f)(1,4)diazepines, process for their preparation, and pharmaceutical compositions containing these compounds
09/11/1991EP0446133A1 4H-Pyrrolo[1,2-a]thieno[3,2-f][1,4]diazepine derivatives, process for their preparation and pharmaceutical compositions containing them
09/11/1991EP0445950A1 Novel pyridine derivatives and processes for their synthesis
09/11/1991EP0445920A2 Use of ethoxy phenoxy acetic acid derivatives against diabetes
09/11/1991EP0445299A1 Inositol derivative and production thereof
09/11/1991CN1054418A Improvements in and relating to (s) -norfluoxetine
09/11/1991CN1013866B Process for preparation of highly pure acarbose
09/10/1991WO1991013892A1 New organic derivative of a metal with a phospholipid structure, use of this derivative as a biomediator, process for isolating this derivative and pharmaceutical compositions containing it
09/10/1991WO1991013870A1 Mercaptoacyl aminolactam endopeptidase inhibitors
09/10/1991US5047554 3-substituted-2-oxindole derivatives
09/10/1991US5047434 1-(3,5-Dihydroxyphenyl)-2-(Tertiary-Butylamino)-Ethanol
09/10/1991US5047429 Treatment of oedema
09/10/1991US5047395 Reduction of oxyradical damage in biomedical applications
09/10/1991US5047333 Method for the preparation of natural human growth hormone in pure form
09/10/1991US5047235 Pharmaceutical preparations having an antihypertensive and cardioprotective effect
09/10/1991CA2077746A1 Mercaptoacyl aminolactam endopeptidase inhibitors
09/10/1991CA2077645A1 Organic derivative of a metal with a phospholipid structure, use of this derivative as a biomediator, process for isolating this derivative and pharmaceutical compositions containing it
09/10/1991CA1288768C Highly pure acarbose
09/10/1991CA1288695C Method for increasing bone mass
09/09/1991CA2037654A1 4h-pyrrolo[1,2-a]thieno[3,2-f][1,4]-diazepines, process for the preparation thereof and pharmaceutical compositions containing the same
09/09/1991CA2037638A1 Pyrrolo[1,2-a]thieno[3,2-f]-diazepines[1,4], process for the preparation thereof and pharmaceutical compositions containing the same
09/08/1991WO1991013907A1 Derivatives of n-phenyl glycinamide, their preparation and medicaments containing them
09/08/1991CA2074375A1 N-phenyl glycinamide derivatives, preparation thereof and drugs containing same
09/08/1991CA2037610A1 Derivatives of 4-(aminomethyl) piperidine, their preparation and their therapeutic application
09/08/1991CA2037590A1 Pyridine derivatives and processes for their synthesis
09/06/1991WO1991013883A1 S-(2-thenoyl)-thiolactic acid derivative having pharmacological activity
09/06/1991CA2077543A1 S-(2-thenoyl)-thiolactic acid derivative having pharmacological activity
09/05/1991WO1991013094A1 Inhibitor of proliferation of endothelial cells
09/05/1991WO1991013076A1 Branched fructo-oligosaccharides, a method for obtaining them and uses of products containing them
09/05/1991WO1991012812A1 Inhibitors of catalytic antibodies
09/05/1991WO1991012803A1 Hydantoin derivatives for use as hypoglycemic and/or hypolipidemic agents
09/05/1991WO1991012799A1 Use of 3-guanidinopropionic acid in the treatment and prevention of metabolic disorders
09/04/1991EP0444931A2 Use of 3-oxygermylpropionic acid to treat and prevent diabetes due to autoimmune diseases
09/04/1991EP0444891A1 Use of a pyrodextrin hydrolysate for the preparation of a food composition for performing improvement of serum lipid
09/04/1991EP0444888A1 Process for the desilylation of a 4-silyloxy-tetrahydro-pyran-2-one
09/04/1991EP0444855A1 Improvements in and relating to (S)-norfluoxetine
09/04/1991EP0444852A2 Crystalline salt of 4-(di-n-propyl)amino-6-aminocarbonyl-1,3,4,5-tetrahydrobenz[cd]indole
09/04/1991EP0444546A1 Hydantoin derivatives for use as hypoglycemic and/or hypolipidemic agents
09/04/1991EP0444533A2 Quinoline and pyridine anchors for HMG-CoA reductase inhibitors
09/04/1991EP0444532A1 Phosphorus-containing HMG-CoA reductase inhibitors, new intermediates and method
09/04/1991EP0444482A2 Oxetanones
09/04/1991EP0444156A1 Method for treating vascular diseases
09/04/1991EP0202276B1 Composition for the treatment of psoriasis
09/03/1991US5045567 Propanolamine derivatives having anti-diabetic effects
09/03/1991US5045562 Antilipemic and antiarteriosclerotic
09/03/1991US5045547 Leukotriene-inhibiting substituted (quinolin-2-yl-methoxy)phenyl-N,N'-sulphonylureas and use thereas
09/03/1991US5045544 N'-alkyl-spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors
09/03/1991US5045324 Pasty dialyzing composition for perfusing artificial kidney systems and process for preparing same
09/03/1991US5045323 Mineral deficiencies in bones; removing contents, centrifuging, washing, rinsing, drying, crushing, grinding, sterilizing
09/03/1991CA2036407A1 Phosphorus-containing hmg-coa reductase inhibitors, new intermediates and method
09/03/1991CA1288435C Substituted hexahydroarylquinolizines
09/02/1991WO1991013903A1 Heterocyclic steroid compounds
09/02/1991WO1991013146A1 Ruminal bacterium for preventing acute lactic acidosis
09/02/1991CA2077680A1 Heterocyclic steroid compounds
08/1991
08/29/1991WO1991012800A1 Use of 3-guanidinopropionic acid in the treatment and prevention of metabolic disorders
08/29/1991CA2037239A1 (s)-norfluoxetine
08/29/1991CA2037199A1 Inhibitors of catalytic antibodies
08/28/1991WO1991013062A2 Substituted 1-(alkoxy-iminoalkyl)imidazole derivatives
08/28/1991EP0444000A2 Storage-stable glucosamine sulphate oral dosage forms and methods for their manufacture
08/28/1991EP0443789A1 Use of refined pyrodextrin hydrolysate
08/28/1991EP0443047A1 Liquid nutrient composition
08/28/1991EP0428668A4 Water-soluble vitamin a preparations for application to the skin
1 ... 1241 1242 1243 1244 1245 1246 1247 1248 1249 1250 1251 1252 1253 1254 1255 1256 1257 1258 1259 1260 1261 ... 1298